HOME_PAGE_HEADER_CONTENT

A female patient and a female physician, representing different ethnicities in conversation A female patient and a female physician, representing different ethnicities in conversation

Passion for Innovation.

Compassion for Patients.

Learn More-HP Updated

Learn More

Corporate Video

For people affected by cancer, Daiichi Sankyo turns hope into possibility. Possibility into reality. Our collective craft is medicine. We’re transforming how cancer and other disease are treated. More than 120 year of heritage inspires us to meet new challenges.

Ken Keller's Professional Adventure of a Lifetime
 
My Greatest Professional Adventure—10 Years in the Making

Ken Keller, President & CEO, Daiichi Sankyo, Inc., and Global Head of Oncology Business on the adventure of a lifetime and how each new one shapes who he is. read more

Those Who Raise You Up: Head of Clinical Science Reflects on Her Role Models
 
Those Who Raise You Up: Head of Clinical Science Reflects on Her Role Models

Dalal Nesheiwat discusses her PharmD experience and the role of family and mentorship in her pursuit of a fulfilling career. read more

Former Heart Surgeon Finds Rewarding Career Outside the OR
 
Former Heart Surgeon Finds Rewarding Career Outside the OR

Michael Grosso talks open heart surgery, Specialty Medicine, and Astronomy. read more

Featured News

Press Releases

Email Alert
Fri Apr 05 00:00:00 GMT-05:00 2024 NEW
ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors Download
Wed Apr 03 00:00:00 GMT-05:00 2024 NEW
REJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan Initiated in Patients with Platinum-Resistant Ovarian Cancer Download
Tue Apr 02 00:00:00 GMT-05:00 2024 NEW
Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer Download
Mon Feb 19 00:00:00 GMT-05:00 2024
Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer Download
View All